The Early Treatment Program (ETP)

The Early Treatment Program at Zucker Hillside Hospital provides state-of-the-art care and research opportunities to adolescents and young adults with newly diagnosed psychotic disorders including schizophrenia and schizoaffective disorder. The team at the Zucker Hillside Hospital has been pioneering early psychosis research for decades and our experts are at the forefront of efforts to understand the etiology of psychotic symptoms as well as improve treatment options and outcomes.

Current research opportunities include:

  • Randomized medication trials in early psychosis
  • Brain imaging
  • Exploring effectiveness of Omega-3 in early psychosis
  • Exploring genetic underpinnings of psychotic disorders
  • Pharmacogenetic testing to guide treatment options
  • Cerebrospinal fluid biomarkers in psychotic disorders
  • Using social media in early psychosis identification and engagement
  • Improving trajectories to care in first episode psychosis

For more information, please contact Asra Rizvi at (718) 470-5352, or visit the Early Treatment Program on the Northwell Health website.